SELLAS Life Sciences prices $9.0M public offering of 12M shares and warrants at $0.75/unit
SELLAS Life Sciences Group, Inc.
- Gross proceeds of $9.0M from sale of 12M shares/common stock equivalents and 12M warrants at $0.75 per unit.
- Warrants exercise price $0.75 per share, immediately exercisable, expire in five years.
- A.G.P./Alliance Global Partners acting as sole placement agent; closing expected Jan 8, 2024.
- Exercise price reduced to $0.75 on ~7.5M warrants from prior issuances; term extended to Jan 8, 2029.